Market Cap

InnoPharmax, Inc. Market Capitalization:

TW$1.81 Billion

TWD as of July 1, 2025

US$61.9 Million

business InnoPharmax, Inc. Company Profile

InnoPharmax, Inc. Main Stock Listing

TWSE: 4172

Market Capitalization History of InnoPharmax, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of InnoPharmax, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 TW$1.86 B 14.24%
Jan. 1, 2024 TW$1.62 B 55.25%
Jan. 1, 2023 TW$1.05 B -32.49%
Jan. 1, 2022 TW$1.55 B 18.60%
Jan. 1, 2021 TW$1.31 B 23.87%
Jan. 1, 2020 TW$1.06 B 34.55%
Jan. 1, 2019 TW$784.1 M -47.50%
Jan. 1, 2018 TW$1.49 B -38.93%
Jan. 1, 2017 TW$2.45 B -26.42%
Jan. 1, 2015 TW$3.32 B -22.80%
Jan. 1, 2014 TW$4.31 B -21.96%
Jan. 1, 2013 TW$5.52 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

InnoPharmax, Inc. Categories

Taiwan languages Healthcare languages Drug Manufacturers—Specialty & Generic
Taiwan Healthcare Taiwan Drug Manufacturers—Specialty & Generic

Stocks & Indices

InnoPharmax, Inc. has the following listings and related stock indices.


Stock: TWSE: 4172

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.